Corrigendum for Yu et al.,
ERRATA |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
References |
|---|
1. Parkin, D. M., P. Pisani, and J. Ferlay. 1993. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer 54: 594-606 [Medline].
2. Valaitis, J., S. Warren, and D. Gamble. 1981. Increasing incidence of adenocarcinoma of the lung. Cancer 41: 1042-1046 .
3. Minna, J. D., H. Pass, E. Glastein, and D. C. Ihde. 1989. Carcinoma of the lung. In V. T. Devita, Jr., S. Hellman, and S. A. Rosenberg, editors. Cancer: Principles and Practice of Oncology. J. B. Lippincott, Philadelphia. 591-703.
4. Sagawa, M., Y. Saito, S. Takahashi, K. Usuda, K. Kamma, M. Sato, S.-I. Ota, N. Nagamoto, S. Fujimura, T. Nakada, K. Hashimoto, H. Suda, T. Imai, and H. Saito. 1990. Clinical and prognostic assessment of patients with resected small peripheral lung cancer lesions. Cancer 66: 2653-2657 [Medline].
5.
Devereux, T. R.,
J. A. Taylor, and
J. C. Barrett.
1996.
Molecular mechanisms of lung cancer: interaction of environmental and genetic factors.
Chest
109(Suppl.):
14S-19S
6. World Health Organization. 1982. The World Health Organization histological typing of lung tumors. Am. J. Clin. Pathol 1982: 123-136 .
7.
Itzkowitz, S. H.,
E. J. Bloom,
W. A. Kokal,
G. Modin,
S. Hakomori, and
Y. S. Kim.
1990.
Sialyl-Tn
a novel mucin antigen associated with
prognosis in colorectal carcinoma patients.
Cancer
66:
1960-1966
[Medline].
8. McGuckin, M. A., M. D. Walsh, B. G. Hohn, B. G. Ward, and R. G. Wright. 1995. Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum. Pathol 26: 432-439 [Medline].
9. Devine, P. L., and I. F. C. McKenzie. 1992. Mucins: structure, function and associations with malignancy. Bioessays 14: 619-625 [Medline].
10. Kawai, T., M. Suzuki, K. Kase, and Y. Ozeki. 1993. Expression of carbohydrate antigens in human pulmonary adenocarcinoma. Cancer 72: 1581-1587 [Medline].
11.
Orawa, J.-I.,
A. Sano,
S. Koide, and
A. Shohtsu.
1994.
Relation between
recurrence and expression of proliferating cell nuclear antigen, sialyl
Lewisx, and sialyl Lewisa in lung cancer.
J. Thorac. Cardiovasc. Surg
108:
329-336
12. Mountain, C. F. 1986. A new international staging system for lung cancer. Chest 89(Suppl. 4):225-233.
13.
Harpole, D. H.,
J. E. Herndon,
W. G. Wolfe,
J. D. Iglehart, and
J. R. Marks.
1995.
A prognostic model of recurrence and death in stage I
non-small-cell lung cancer utilizing presentation, histopathology, and
oncoprotein expression.
Cancer Res
55:
51-56
14. Xerri, L., M.-J. Payan, R. Choux, N. Gros, D. Figarella-Branger, and H. Sarles. 1990. Predominance of sialomucin secretion in malignant and premalignant pancreatic lesions. Hum. Pathol 21: 927-931 [Medline].
15. Glantz, S. A. 1987. Primer of Biostatics, 2nd ed. McGraw-Hill, New York. 101-137.
16. Kaplan, E. L., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Statist. Assoc 53: 457-481 .
17. Cox, D. R.. 1972. Regression Models and life tables. J. R. Stat. Soc. (Series B) 34: 187-200 .
18.
Linnoila, R. I.,
S. Piantadosi, and
J. C. Ruckdeschel.
1994.
Impact of neuroendocrine differentiation in non-small-cell lung carcinoma: the LCSG
experience.
Chest
106(Suppl.):
367S-371S
19.
Graziano, S. L.,
A. H. Tatum,
N. B. Newman,
A. Oler,
L. J. Kohman,
L. J. Veit,
G. P. Gamble,
M. J. Coleman,
S. Barmada, and
S. O'Lear.
1994.
The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small-cell lung cancer.
Cancer Res
54:
2908-2913
20. Clayton, F.. 1986. Bronchioloalveolar carcinomas: cell types, patterns of growth, and prognostic correlates. Cancer 57: 1555-1564 [Medline].
21.
Correa, P..
1988.
A human model of gastric carcinogenesis.
Cancer Res
48:
3554-3560
22. Allen, D. C., N. S. Connolly, and J. D. Biggart. 1988. High iron diamine-alcian blue mucin profiles in benign, premalignant and malignant colorectal disease. Histopathology 13: 399-411 [Medline].
23.
Otaga, S.,
P. J. Maimonis, and
S. H. Itzkowitz.
1992.
Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity.
Cancer Res
52:
4741-4746
24. Gendler, S. J., and A. P. Spicer. 1995. Epithelial mucin genes. Annu. Rev. Physiol 57: 607-634 [Medline].
25. Hilkens, J., M. J. L. Lightenberg, H. L. Vos, and S. V. Litvinov. 1992. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem. Sci 17: 359-363 [Medline].
26.
Charest, M. P., and
J. Roth.
1985.
Localization of sialic acid in kidney
glomeruli: regionalization in the podocyte plasma membrane and loss
in experimental nephrosis.
Proc. Natl. Acad. Sci. U.S.A
82:
8508-8512
27. Ho, J. J. L., S. Chang, and Y. S. Kim. 1995. Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids. Biochem. Biophys. Res. Commun 210: 866-873 [Medline].
28. Yogeeswaran, G.. 1982. Cell membrane glycolipids and glycoproteins in malignant transformation. Adv. Cancer Res 38: 289-350 .
29. Petrick, A. T., S. Meterissian, G. Steele Jr., and P. Thomas. 1994. Desialylation of human colorectal carcinoma cells facilitates binding to Kupffer cells. Clin. Exp. Metastasis 12: 108-116 [Medline].
30. Kakari, S., E. Stringou, M. Toumbis, A. S. Ferderigos, E. Poulaki, K. Chondros, A. Dema, V. Kotsovoulou, and N. Pavlidis. 1991. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid. Anticancer Res 11: 2107-2110 [Medline].
31. Thomas, P.. 1996. Cell surface sialic acid as a mediator of metastatic potential in colorectal cancer. Cancer J 9: 32-36 .
32.
Kern, J. A.,
D. A. Schwartz,
J. E. Nordberg,
D. B. Weiner,
M. Greene II,
L. Torney, and
R. A. Robinson.
1990.
p185neu expression in human
lung adenocarcinomas predicts shortened survival.
Cancer Res
50:
5184-5191
33.
Wu, K.,
N. Fregein, and
K. L. Carraway.
1994.
Molecular cloning and sequencing of the mucin subunit of a heterodimeric, bifunctional cell
surface glycoprotein complex of ascites rat mammary adenocarcinoma cells.
J. Biol. Chem
269:
11950-11955
34. Satoh, K., H. Sasano, T. Shimosegawa, M. Koizumi, T. Yamazaki, F. Mochizuki, N. Kobayashi, T. Okano, T. Toyota, and T. Sawai. 1993. An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas. Cancer 72: 51-56 [Medline].
35.
Carbone, D. P.,
T. Mitsudomi,
I. Chiba,
S. Piantadosi,
V. Rusch,
J. A. Nowak,
D. McIntyre,
D. Slamon,
A. Gazdar, and
J. Minna.
1994.
P53 immunostaining positivity is associated with reduced survival and is
imperfectly correlated with gene mutations in resected non-small cell
lung cancer: a preliminary report of LCSG 871.
Chest
106(Suppl.):
377S-381S
| ||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |